163 related articles for article (PubMed ID: 10923858)
21. Inhibitory effect of rifampicin on the depressive action of interleukin-1 on cytochrome P-450-linked monooxygenase system.
Kurokohchi K; Yoneyama H; Nishioka M; Ichikawa Y
Metabolism; 2001 Feb; 50(2):231-6. PubMed ID: 11229434
[TBL] [Abstract][Full Text] [Related]
22. Tissue distributions of CYP2D1, 2D2, 2D3 and 2D4 mRNA in rats detected by RT-PCR.
Hiroi T; Imaoka S; Chow T; Funae Y
Biochim Biophys Acta; 1998 May; 1380(3):305-12. PubMed ID: 9555068
[TBL] [Abstract][Full Text] [Related]
23. Polymorphic debrisoquine 4-hydroxylase activity in the rat is due to differences in CYP2D2 expression.
Schulz-Utermoehl T; Bennett AJ; Ellis SW; Tucker GT; Boobis AR; Edwards RJ
Pharmacogenetics; 1999 Jun; 9(3):357-66. PubMed ID: 10471068
[TBL] [Abstract][Full Text] [Related]
24. Molecular basis of the Dark Agouti rat drug oxidation polymorphism: importance of CYP2D1 and CYP2D2.
Yamamoto Y; Tasaki T; Nakamura A; Iwata H; Kazusaka A; Gonzalez FJ; Fujita S
Pharmacogenetics; 1998 Feb; 8(1):73-82. PubMed ID: 9511184
[TBL] [Abstract][Full Text] [Related]
25. An evaluation of cytochrome P450 isoform activities in the female dark agouti (DA) rat: relevance to its use as a model of the CYP2D6 poor metaboliser phenotype.
Barham HM; Lennard MS; Tucker GT
Biochem Pharmacol; 1994 Apr; 47(8):1295-307. PubMed ID: 8185638
[TBL] [Abstract][Full Text] [Related]
26. Developmental changes in the catalytic activity and expression of CYP2D isoforms in the rat liver.
Chow T; Imaoka S; Hiroi T; Funae Y
Drug Metab Dispos; 1999 Feb; 27(2):188-92. PubMed ID: 9929501
[TBL] [Abstract][Full Text] [Related]
27. Expression of four rat CYP2D isoforms in Saccharomyces cerevisiae and their catalytic specificity.
Wan J; Imaoka S; Chow T; Hiroi T; Yabusaki Y; Funae Y
Arch Biochem Biophys; 1997 Dec; 348(2):383-90. PubMed ID: 9434752
[TBL] [Abstract][Full Text] [Related]
28. Expression, purification, and characterization of mouse CYP2d22.
Yu AM; Haining RL
Drug Metab Dispos; 2006 Jul; 34(7):1167-74. PubMed ID: 16595712
[TBL] [Abstract][Full Text] [Related]
29. In situ hybridization study of CYP2D mRNA in the common marmoset brain.
Shimamoto Y; Niimi K; Kitamura H; Tsubakishita S; Takahashi E
Exp Anim; 2016 Nov; 65(4):465-471. PubMed ID: 27356856
[TBL] [Abstract][Full Text] [Related]
30. The unique regulation of brain cytochrome P450 2 (CYP2) family enzymes by drugs and genetics.
Miksys S; Tyndale RF
Drug Metab Rev; 2004 May; 36(2):313-33. PubMed ID: 15237857
[TBL] [Abstract][Full Text] [Related]
31. Constitutive expression and localization of the major drug metabolizing enzyme, cytochrome P4502D in human brain.
Chinta SJ; Pai HV; Upadhya SC; Boyd MR; Ravindranath V
Brain Res Mol Brain Res; 2002 Jun; 103(1-2):49-61. PubMed ID: 12106691
[TBL] [Abstract][Full Text] [Related]
32. Stable expression of human cytochrome P450 2D6*10 in HepG2 cells.
Zhuge J; Yu YN; Wu XD
World J Gastroenterol; 2004 Jan; 10(2):234-7. PubMed ID: 14716830
[TBL] [Abstract][Full Text] [Related]
33. Down-regulation of hepatic CYP3A in chronic renal insufficiency.
Rege B; Krieg R; Gao N; Sarkar MA
Pharm Res; 2003 Oct; 20(10):1600-6. PubMed ID: 14620514
[TBL] [Abstract][Full Text] [Related]
34. Brain microsomal metabolism of phencyclidine in male and female rats.
Laurenzana EM; Owens SM
Brain Res; 1997 May; 756(1-2):256-65. PubMed ID: 9187340
[TBL] [Abstract][Full Text] [Related]
35. The Atypical Antipsychotic Lurasidone Affects Brain but Not Liver Cytochrome P450 2D (CYP2D) Activity. A Comparison with Other Novel Neuroleptics and Significance for Drug Treatment of Schizophrenia.
Danek PJ; Daniel WA
Cells; 2022 Nov; 11(21):. PubMed ID: 36359909
[TBL] [Abstract][Full Text] [Related]
36. Stereoselective metabolism of cibenzoline, an antiarrhythmic drug, by human and rat liver microsomes: possible involvement of CYP2D and CYP3A.
Niwa T; Shiraga T; Mitani Y; Terakawa M; Tokuma Y; Kagayama A
Drug Metab Dispos; 2000 Sep; 28(9):1128-34. PubMed ID: 10950860
[TBL] [Abstract][Full Text] [Related]
37. Human CYP2D6 and mouse CYP2Ds: organ distribution in a humanized mouse model.
Miksys SL; Cheung C; Gonzalez FJ; Tyndale RF
Drug Metab Dispos; 2005 Oct; 33(10):1495-502. PubMed ID: 16033950
[TBL] [Abstract][Full Text] [Related]
38. Regional and cellular expression of CYP2D6 in human brain: higher levels in alcoholics.
Miksys S; Rao Y; Hoffmann E; Mash DC; Tyndale RF
J Neurochem; 2002 Sep; 82(6):1376-87. PubMed ID: 12354285
[TBL] [Abstract][Full Text] [Related]
39. Regioselectivity and substrate concentration-dependency of involvement of the CYP2D subfamily in oxidative metabolism of amitriptyline and nortriptyline in rat liver microsomes.
Masubuchi Y; Iwasa T; Fujita S; Suzuki T; Horie T; Narimatsu S
J Pharm Pharmacol; 1996 Sep; 48(9):925-9. PubMed ID: 9036183
[TBL] [Abstract][Full Text] [Related]
40. Molecular evolution of the CYP2D subfamily in primates: purifying selection on substrate recognition sites without the frequent or long-tract gene conversion.
Yasukochi Y; Satta Y
Genome Biol Evol; 2015 Mar; 7(4):1053-67. PubMed ID: 25808902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
